Intervention Review

Depot fluphenazine decanoate and enanthate for schizophrenia

  1. Anthony David1,*,
  2. Clive E Adams2,
  3. Maurice Eisenbruch3,
  4. Seema N Quraishi1,
  5. John Rathbone4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 APR 2004

Assessed as up-to-date: 21 JAN 2004

DOI: 10.1002/14651858.CD000307

How to Cite

David A, Adams CE, Eisenbruch M, Quraishi SN, Rathbone J. Depot fluphenazine decanoate and enanthate for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD000307. DOI: 10.1002/14651858.CD000307.

Author Information

  1. 1

    Institute of Psychiatry, London, UK

  2. 2

    University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  3. 3

    University of New South Wales, WHO Regional Centre for Health Development, Sydney, Australia

  4. 4

    The University of Sheffield, HEDS, ScHARR, Sheffield, UK

*Anthony David, Institute of Psychiatry, De Crespigny Park, BOX PO68, London, SE5 8AF, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004